SUBSCRIBE
SUBSCRIBE
Joseph Mattingly

T. Joseph Mattingly II

Opinion author

Joey Mattingly, PharmD, MBA, PhD, is an associate professor and vice chair of research in the Department of Pharmacotherapy at The University of Utah College of Pharmacy. He is a research fellow for the National Association of Insurance Commissioners (NAIC) and previously served as an advisor to the Centers for Medicare & Medicaid Services.

White and multi colored pills on white background top view
Opinion
IRA’s Definition of ‘Drug’ Creates Confusion for Developers
Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price negotiation purposes—even if approved by the FDA under a separate application—disincentivizing companies from investing time and money in gaining approval for new formulations and indications.
July 30, 2025
 · 
6 min read
 · 
T. Joseph Mattingly II